david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.members of the cavanagh family on the final day of the inquest into the death of brigid cavanagh from foyle park in londonderry
.